Chris De Savi, based in Boston, MA, US, is currently a CSO Partner at Curie.Bio, bringing experience from previous roles at Curie.Bio, Drug Hunting Literature Group and Kymera Therapeutics. Chris De Savi holds a Queens' College Fellow in Chemistry @ University of Cambridge. With a robust skill set that includes Drug Discovery, Medicinal Chemistry, Drug Design, Organic Chemistry, Oncology and more, Chris De Savi contributes valuable insights to the industry. Chris De Savi has 1 email and 1 mobile phone number on RocketReach.